Indication
Gastric Junction Cancer
2 clinical trials
9 products
Product
zolbetuximabProduct
oxaliplatinProduct
leucovorinProduct
fluorouracilClinical trial
A Phase 2 Study of Zolbetuximab (IMAB362) as Monotherapy and in Combination With Chemotherapy and/or Immunotherapy in Subjects With Metastatic or Locally Advanced Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma and Locoregional Gastric or GEJ Adenocarcinoma Whose Are Claudin (CLDN) 18.2 PositiveStatus: Recruiting, Estimated PCD: 2025-04-30
Product
nivolumabProduct
PembrolizumabProduct
Folinic acidProduct
DocetaxelProduct
ZolbetuximabClinical trial
A Phase 1 Open-label Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaStatus: Completed, Estimated PCD: 2020-06-09